Across TCGA pan-cancer cohorts, ATP5MFP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ATP5MFP1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where ATP5MFP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATP5MFP1 is over-expressed in tumor.

BLCA, LUSC, and BRCA are the cancer types where ATP5MFP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATP5MFP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.130	.007	5	view →
LUSC	All	All	+0.083	.014	2	view →
BRCA	Female	All	+0.075	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ATP5MFP1 RNA expression & survival · all ATP5MFP1 data types